In 2015, a study on breast cancer that used molecular barcoding to follow the path of metastatic cells from the primary to the metastatic site, suggested vascular mimicry (VM) as a driver of intravasation due to the action of two secreted proteins—SERPINE2 and Slpi15. This evidence concerns the gene SERPINE2 and breast cancer.